CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Nurix Therapeutics falls 2% following Q3 earnings as operating expenses up

EarningsNegative
AI Analysis

Summary

Nurix Therapeutics stock declined 2% following Q3 earnings report, with the company reporting increased operating expenses.

Importance:3/10
Sentiment:
-0.30
earningsoperating_expensesstock_decline
Related Companies

Read the original article

Published by yahoo_finance on October 12, 2026 8:59 PM

Read Original